Independent information service
Practical guides, comparison tools, research summaries, and question frameworks for Australians trying to understand ibogaine without mistaking information for treatment advice.
Still Threshold 52 is an independent resource on ibogaine risks, evidence, and Australian pathways.
A careful starting point
Our offerings are informational: they help readers sort claims, identify unanswered questions, and understand why health and legal decisions need qualified, local advice.
The practical Australian guide to ibogaine provides the shared starting point for this work. It is designed for people affected by substance dependence, as well as families and support people seeking plain language rather than promotional promises.
For the purpose and limits behind the resource, our approach to independent information explains why evidence, uncertainty, harm reduction, and informed choice sit ahead of certainty or sales language.
What we provide
Plainspoken guides organise the practical questions around ibogaine, Australian context, uncertainty, and safety. They are written to support informed discussion, not self-treatment or overseas retreat claims.
Structured prompts help separate what is known, what remains uncertain, and which questions belong with a qualified health professional or legal adviser.
Comparison pages place claims alongside risks, limits of evidence, and evidence-based options. The aim is to reduce false certainty rather than steer anyone toward a particular pathway.
Research summaries translate technical terms and distinguish early findings from established care. The Texas ibogaine bill context can also illustrate why jurisdiction-specific policy questions should not be treated as interchangeable.
Interactive question set
Research should be read with attention to study design, uncertainty, adverse events, and whether findings apply to a particular person or setting. A useful starting reference is the overview of ibogaine, while primary health advice requires a qualified clinician.
Ibogaine has been associated with serious medical risks, including cardiac concerns. A safety-focused review should not replace clinical assessment; it should make clear why screening, medication interactions, and emergency capacity are significant questions.
Australian readers can distinguish broad online claims from local health, regulatory, and support pathways. The Therapeutic Goods Administration explains its role in the Australian therapeutic goods framework, which is relevant context for questions about medicines and regulation.
“Evidence before claims; questions before conclusions.”
Still Threshold 52 does not provide medical treatment, assess individual suitability, or arrange services. It is built to help readers recognise when a claim is too broad, a source is too weak, or a decision needs professional support.
That distinction matters because treatment for substance dependence may involve established supports and individual clinical assessment. The Australian Government’s alcohol and other drugs information is one starting point for understanding the wider public-health context.
How to use the resource
These information services work best as a sequence: establish the context, test a claim, consider risks, then take questions to an appropriate professional or support service.
Continue carefully
Use the resource to prepare better questions around risks, evidence, and Australian pathways. It is information for informed choice, not a substitute for medical or legal advice.
Explore practical questions